Jinxin Fertility Group Limited (HKG:1951)
Hong Kong · Delayed Price · Currency is HKD 2.480
+0.040 (1.64%)
At close: Feb 13, 2026
Jinxin Fertility Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 2,656 | 2,812 | 2,789 | 2,364 | 1,839 | 1,426 | |
Revenue Growth (YoY) | -8.36% | 0.81% | 17.95% | 28.59% | 28.94% | -13.49% |
Cost of Revenue | 1,749 | 1,712 | 1,613 | 1,451 | 1,067 | 860.31 |
Gross Profit | 907.85 | 1,099 | 1,175 | 913.13 | 771.48 | 565.78 |
Selling, General & Admin | 624.02 | 633.18 | 673.23 | 610.29 | 389.45 | 316.62 |
Research & Development | 22.83 | 24.69 | 21.75 | 17.47 | 10.65 | 11.48 |
Operating Expenses | 646.86 | 657.87 | 694.97 | 627.76 | 400.1 | 328.1 |
Operating Income | 260.99 | 441.58 | 480.47 | 285.37 | 371.39 | 237.68 |
Interest Expense | -71.95 | -57.41 | -79.64 | -71.85 | -21.15 | -13.39 |
Interest & Investment Income | 6.86 | 7.48 | 20.71 | 28.35 | 34.45 | 48.62 |
Earnings From Equity Investments | 7.2 | 5.15 | 4.95 | -4.37 | -10.11 | - |
Currency Exchange Gain (Loss) | -26.02 | -24.17 | 3.99 | 9.42 | 13.12 | 42.2 |
Other Non Operating Income (Expenses) | -89.83 | 24.11 | 27.69 | 15.96 | 29.37 | 7.62 |
EBT Excluding Unusual Items | 87.25 | 396.74 | 458.16 | 262.87 | 417.07 | 322.74 |
Gain (Loss) on Sale of Investments | -6.5 | -4.89 | 6.12 | -35.4 | 40.86 | 20.53 |
Gain (Loss) on Sale of Assets | -0.59 | -0.06 | -1.07 | -34.54 | -0 | 0.05 |
Other Unusual Items | -49.96 | 0.1 | 1.05 | -38.61 | - | 5.82 |
Pretax Income | -962.37 | 391.89 | 464.27 | 154.32 | 457.93 | 349.13 |
Income Tax Expense | -1.4 | 118.42 | 117.29 | 36.38 | 104.23 | 88.64 |
Earnings From Continuing Operations | -960.97 | 273.47 | 346.98 | 117.95 | 353.7 | 260.5 |
Minority Interest in Earnings | 14.47 | 9.63 | -2.26 | 3.18 | -13.8 | -8.87 |
Net Income | -946.5 | 283.1 | 344.72 | 121.12 | 339.9 | 251.62 |
Net Income to Common | -946.5 | 283.1 | 344.72 | 121.12 | 339.9 | 251.62 |
Net Income Growth | - | -17.88% | 184.60% | -64.37% | 35.08% | -38.57% |
Shares Outstanding (Basic) | 2,677 | 2,681 | 2,676 | 2,496 | 2,478 | 2,400 |
Shares Outstanding (Diluted) | 2,677 | 2,719 | 2,736 | 2,624 | 2,504 | 2,416 |
Shares Change (YoY) | -1.53% | -0.61% | 4.24% | 4.80% | 3.67% | 9.49% |
EPS (Basic) | -0.35 | 0.11 | 0.13 | 0.05 | 0.14 | 0.10 |
EPS (Diluted) | -0.36 | 0.10 | 0.12 | 0.05 | 0.14 | 0.10 |
EPS Growth | - | -18.38% | 154.93% | -64.63% | 35.88% | -46.32% |
Free Cash Flow | 216.09 | 366.84 | 510.92 | -417.65 | 263.62 | 41.89 |
Free Cash Flow Per Share | 0.08 | 0.14 | 0.19 | -0.16 | 0.10 | 0.02 |
Dividend Per Share | - | - | 0.050 | - | 0.060 | - |
Gross Margin | 34.17% | 39.10% | 42.15% | 38.62% | 41.95% | 39.67% |
Operating Margin | 9.83% | 15.71% | 17.23% | 12.07% | 20.20% | 16.67% |
Profit Margin | -35.63% | 10.07% | 12.36% | 5.12% | 18.48% | 17.64% |
Free Cash Flow Margin | 8.13% | 13.05% | 18.32% | -17.66% | 14.34% | 2.94% |
EBITDA | 488.15 | 645.06 | 682.02 | 476.22 | 494.08 | 331.91 |
EBITDA Margin | 18.38% | 22.94% | 24.45% | 20.14% | 26.87% | 23.27% |
D&A For EBITDA | 227.16 | 203.48 | 201.55 | 190.85 | 122.7 | 94.23 |
EBIT | 260.99 | 441.58 | 480.47 | 285.37 | 371.39 | 237.68 |
EBIT Margin | 9.83% | 15.71% | 17.23% | 12.07% | 20.20% | 16.67% |
Effective Tax Rate | - | 30.22% | 25.26% | 23.57% | 22.76% | 25.39% |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.